Combined agents for treatment of glaucoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5575 (2006.01) A61K 31/41 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2392804

[Object] To provide an agent for prophylaxis or treatment of glaucoma. [Solution] An agent for the prophylaxis or treatment of glaucoma, which comprises an angiotensin II antagonist and at least one compound selected from adrenaline receptor blockers, prostaglandins and carbonic anhydrase inhibitors as active ingredients for simultaneous, separate or successive use of these active ingredients.

Cette invention concerne des médicaments contre le glaucome administrés à titre préventif ou curatif. Ces médicaments renferment, comme principes actifs, un antagoniste de l'angiotensine II et au moins un composé pris parmi des agents bloquants du récepteur de l'adrénaline, des inhibiteurs de la carbonate déshydratase et des prostaglandines. Ces médicaments s'utilisent simultanément, séparément ou successivement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined agents for treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined agents for treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined agents for treatment of glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1502544

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.